U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07945704) titled 'GLP-1 RAs and Dietary Intake and Body Composition' on Nov. 06.
Brief Summary: To assess longitudinal changes in dietary intake, body composition and metabolism with GLP-1 RA use.
Study Start Date: June 01
Study Type: OBSERVATIONAL
Condition:
Glucagon-Like Peptide-1 Receptor Agonists
Metabolism
Body Composition
Intervention:
DRUG: GLP-1 RAs
Participants currently taking GLP-1 RAs as part of their care
Recruitment Status: RECRUITING
Sponsor: Ohio University
Information provided by (Responsible Party): Angela Hillman, Ohio University
Published by HT Digital Content Services with permission from Health Daily Digest....